ECM
ANIP icon

ETrade Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

ETrade Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,324
Closed -$870K – 796
2018
Q4 		$870K Sell
19,324
-876
-4% -$45.9K 0.03% 337
2018
Q3 		$1.14M Buy
20,200
+1,654
+9% +$101K 0.03% 331
2018
Q2 		$1.24M Sell
18,546
-68
-0.4% -$4.25K 0.04% 292
2018
Q1 		$1.08M Sell
18,614
-5,218
-22% -$331K 0.03% 322
2017
Q4 		$1.54M Sell
23,832
-593
-2% -$36.9K 0.05% 236
2017
Q3 		$1.28M Buy
24,425
+11,435
+88% +$545K 0.05% 250
2017
Q2 		$608K Buy
12,990
+640
+5% +$30.9K 0.02% 416
2017
Q1 		$611K Buy
12,350
+472
+4% +$26.5K 0.03% 395
2016
Q4 		$720K Sell
11,878
-71
-0.6% -$4.34K 0.03% 330
2016
Q3 		$793K Buy
+11,949
New +$747K 0.04% 290

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ETrade Capital Management's ANIP Position: Q1 2019 in Review

ETrade Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2019, closing a stake of 19,324 shares — an estimated $870K sold.

ETrade Capital Management first reported a position in ANIP in Q3 2016 and held it in 10 quarters. The position peaked at $1.54M in Q4 2017. 190 funds tracked by Wall St. Rank hold ANIP as of Q1 2019.

  • ETrade Capital Management reported no remaining ANI Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • ETrade Capital Management sold 19,324 ANI Pharmaceuticals shares in Q1 2019, an estimated $870K.
  • ETrade Capital Management first reported a position in ANI Pharmaceuticals in Q3 2016 and held it in 10 quarters.
  • ETrade Capital Management's ANI Pharmaceuticals position peaked at $1.54M in Q4 2017.
  • 190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2019.

Based on ETrade Capital Management's 13F filing for Q1 2019, filed 13 May 2019.